PH14575A - An improved tablet formulation - Google Patents

An improved tablet formulation

Info

Publication number
PH14575A
PH14575A PH16805A PH16805A PH14575A PH 14575 A PH14575 A PH 14575A PH 16805 A PH16805 A PH 16805A PH 16805 A PH16805 A PH 16805A PH 14575 A PH14575 A PH 14575A
Authority
PH
Philippines
Prior art keywords
tablet formulation
improved tablet
improved
formulation
tablet
Prior art date
Application number
PH16805A
Inventor
J Spence
Allan J Torode
D Harden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH14575(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH14575A publication Critical patent/PH14575A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH16805A 1974-02-14 1975-02-13 An improved tablet formulation PH14575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (1)

Publication Number Publication Date
PH14575A true PH14575A (en) 1981-09-24

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16805A PH14575A (en) 1974-02-14 1975-02-13 An improved tablet formulation

Country Status (32)

Country Link
JP (1) JPS5545043B2 (en)
AT (1) AT344915B (en)
AU (1) AU468465B2 (en)
BE (1) BE825496A (en)
CA (1) CA980688A (en)
CH (1) CH618432A5 (en)
CS (1) CS220306B2 (en)
CY (1) CY1052A (en)
DD (1) DD118228A5 (en)
DE (1) DE2506099C2 (en)
DK (1) DK143247C (en)
DO (1) DOP1979002763A (en)
ES (1) ES434688A1 (en)
FI (1) FI62219C (en)
FR (1) FR2260993B1 (en)
GB (1) GB1499672A (en)
GT (1) GT197960431A (en)
HK (1) HK23980A (en)
HU (1) HU171536B (en)
IE (1) IE40599B1 (en)
IL (1) IL46629A (en)
IN (1) IN141019B (en)
KE (1) KE3038A (en)
LU (1) LU71835A1 (en)
MC (1) MC1053A1 (en)
MY (1) MY8100054A (en)
NL (1) NL157501C (en)
NO (1) NO146043C (en)
PH (1) PH14575A (en)
SE (1) SE427898B (en)
ZA (1) ZA75930B (en)
ZM (1) ZM1875A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
NO146043B (en) 1982-04-13
JPS5545043B2 (en) 1980-11-15
CS220306B2 (en) 1983-03-25
FR2260993A1 (en) 1975-09-12
GB1499672A (en) 1978-02-01
GT197960431A (en) 1981-05-05
HK23980A (en) 1980-05-09
ES434688A1 (en) 1977-04-01
HU171536B (en) 1978-01-28
DK143247B (en) 1981-08-03
DE2506099C2 (en) 1983-11-03
NL7501680A (en) 1975-08-18
CY1052A (en) 1980-08-01
IL46629A0 (en) 1975-05-22
DK52875A (en) 1975-10-06
CA980688A (en) 1975-12-30
IE40599B1 (en) 1979-07-04
JPS50116627A (en) 1975-09-12
DOP1979002763A (en) 1987-06-18
KE3038A (en) 1980-04-25
DE2506099A1 (en) 1975-08-21
IN141019B (en) 1977-01-08
AU7817075A (en) 1976-01-15
ZA75930B (en) 1976-01-28
MY8100054A (en) 1981-12-31
FI62219C (en) 1982-12-10
DD118228A5 (en) 1976-02-20
IE40599L (en) 1975-08-14
AU468465B2 (en) 1976-01-15
CH618432A5 (en) 1980-07-31
ATA108475A (en) 1977-12-15
ZM1875A1 (en) 1975-12-22
BE825496A (en) 1975-05-29
DK143247C (en) 1981-11-30
NL157501C (en) 1981-07-16
NO146043C (en) 1982-08-04
MC1053A1 (en) 1976-02-20
SE427898B (en) 1983-05-24
FR2260993B1 (en) 1978-06-30
LU71835A1 (en) 1975-06-24
IL46629A (en) 1977-07-31
FI62219B (en) 1982-08-31
SE7501595L (en) 1975-08-15
NO750467L (en) 1975-08-15
FI750398A (en) 1975-08-15
AT344915B (en) 1978-08-25
NL157501B (en) 1978-08-15

Similar Documents

Publication Publication Date Title
GR57850B (en) Testing formulation
AU7915675A (en) Alkoxycarbonylphenylureas
PH14575A (en) An improved tablet formulation
ZA76829B (en) Tablet formulation
CY941A (en) Tablet formulation
JPS5151548A (en) Nyu aruiha hoeenorenzokutekidatsuenhoho
JPS5120688A (en) Roran c jushinkyo fuirutasochi
ZA755515B (en) Pharmaceutical formulations
ZM2976A1 (en) Tablet formulation
JPS5126889A (en) Sefuarosuhorin c no saishuho
ZA757295B (en) Hypolipemising drug
JPS5132791A (en) Sefuarosuhorin c nosaishu seiseiho
JPS5121274A (en) C gatapuresuseikeikakoteiisochi
AU7852875A (en) 5-cyano-thiophen-2-aldehyde-isothiosemicarbazones
AU7697474A (en) Ellipsograph
AU7952675A (en) Tetrahydrobenzisoindolines
IE39585B1 (en) Pharmaceutical compostitions
HU171895B (en) Construcrion set
ZA757088B (en) Testing formulation
HK54180A (en) 6-methyl-8beta-(2-pyridylthiomethyl)ergolene
ZA752042B (en) Pharmaceutical composition with an antiulcus-activity
JPS5151547A (en) Nyu aruiha hoeenodatsuenhoho
JPS5115610A (en) Chitokuroomu c yoekino anteikaho
JPS5176094A (en) Roran c jushinki
AU7246074A (en) Transfers

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 15